Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $50.51 million as of February 18, 2026. Its market cap has increased by 309.88% in one year.

Market Cap

50.51M

Enterprise Value

51.35M

Revenue

41.92M

Ranking

n/a

PE Ratio

16.81

Stock Price

$1.82

Market Cap Chart

Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 50.51M, a decrease of -77.24%. That is a compound annual growth rate of -5.19%.

Market Cap History

Date	Market Cap	% Change
Feb 17, 2026	50.51M	827.14%
Dec 31, 2025	5.45M	-54.11%
Dec 31, 2024	11.87M	152.98%
Dec 29, 2023	4.69M	5.76%
Dec 30, 2022	4.44M	-85.77%
Dec 31, 2021	31.18M	145.72%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Global Cord Blood	127.22M
China New Energy Group Company	73.43M
Bioqual	33.55M
Longduoduo Company	17.81M
Aspira Women's Health	16.57M
Psychemedics	9.30M
Hypha Labs	5.13M
Stella Diagnostics	4.22M

Market Cap Rankings